Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Su TH"" wg kryterium: Autor


Tytuł :
Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Children With a Normal Alanine Aminotransferase Level.
Autorzy :
Chen HS; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Pediatrics, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu City, Taiwan.
Wu JF; Department of Pediatrics, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
Su TH; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
Chen HL; Department of Pediatrics, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
Hsu HY; Department of Pediatrics, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
Xia NS; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, China.
Chen PJ; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
Chang MH; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Pediatrics, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
Pokaż więcej
Źródło :
Hepatology (Baltimore, Md.) [Hepatology] 2019 Dec; Vol. 70 (6), pp. 1903-1912. Date of Electronic Publication: 2019 Aug 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Seroconversion*
Alanine Transaminase/*blood
Hepatitis B Antibodies/*blood
Hepatitis B Core Antigens/*immunology
Hepatitis B e Antigens/*blood
Hepatitis B, Chronic/*immunology
Adolescent ; Child ; Female ; Follow-Up Studies ; Humans ; Male ; Young Adult
Czasopismo naukowe
Tytuł :
Letter to the Editor: Deliberations More Than a Cut-off Hepatitis B Surface Antigen Value for Nucleos(t)ide Analogue Cessation.
Autorzy :
Jeng WJ; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Branch, Taiwan.; Chang Gung University College of Medicine, Taiwan.
Hsu YC; Department of Medical Research, Fu-Jen Catholic University Hospital, Taiwan.; Division of Gastroenterology, Fu-Jen Catholic University Hospital, New Taipei, Taiwan.
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen CH; Chang Gung University College of Medicine, Taiwan.; Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Pokaż więcej
Źródło :
Hepatology (Baltimore, Md.) [Hepatology] 2019 Oct; Vol. 70 (4), pp. 1488-1489.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
Hepatitis B, Chronic*
Hepatitis B Surface Antigens ; Hepatitis B e Antigens ; Hepatitis B virus ; Humans
Raport
Tytuł :
Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma.
Autorzy :
Liao SH; National Taiwan University Cancer Center, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Jeng YM; Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan.
Liang PC; Department of Medical Imaging, National Taiwan University Hospital, Taipei, Taiwan.
Chen DS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Chen CH; Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin County, Taiwan.; National Taiwan University College of Medicine, Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Pokaż więcej
Źródło :
Hepatology (Baltimore, Md.) [Hepatology] 2019 Jan; Vol. 69 (1), pp. 209-221.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Hepatocellular/*mortality
Carcinoma, Hepatocellular/*pathology
Liver Neoplasms/*mortality
Liver Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B.
Autorzy :
Papatheodoridis GV; Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece.
Manolakopoulos S; Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece.; 2nd Department of Internal Medicine, Medical School of National and Kapodistrian University of Athens, Hippokratio General Hospital, Athens, Greece.
Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Siakavellas S; Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece.
Liu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Kourikou A; 2nd Department of Internal Medicine, Medical School of National and Kapodistrian University of Athens, Hippokratio General Hospital, Athens, Greece.
Yang HC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
Hepatology (Baltimore, Md.) [Hepatology] 2018 Aug; Vol. 68 (2), pp. 415-424. Date of Electronic Publication: 2018 May 10.
Typ publikacji :
Journal Article
MeSH Terms :
Antiviral Agents/*therapeutic use
Hepatitis B, Chronic/*drug therapy
Adult ; DNA, Viral ; Female ; Follow-Up Studies ; Hepatitis B e Antigens ; Humans ; Male ; Middle Aged ; Recurrence ; Retreatment/statistics & numerical data ; Treatment Outcome ; Withholding Treatment/statistics & numerical data
Czasopismo naukowe
Tytuł :
HCC risk in patients with HBV-related cirrhosis receiving nucleos(t)ide analogues therapy: Is HCC prevented or delayed?
Autorzy :
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Tseng TC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital Jinshan Branch, New Taipei City, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
Hepatology (Baltimore, Md.) [Hepatology] 2018 Apr; Vol. 67 (4), pp. 1634-1635. Date of Electronic Publication: 2018 Feb 27.
Typ publikacji :
Letter; Comment
MeSH Terms :
Hepatitis B, Chronic*
Liver Cirrhosis*
Antiviral Agents ; Carcinoma, Hepatocellular ; Hepatitis B virus ; Humans ; Liver Neoplasms ; Treatment Outcome
Opinia redakcyjna
Tytuł :
Reply.
Autorzy :
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen CL; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
Hepatology (Baltimore, Md.) [Hepatology] 2016 Nov; Vol. 64 (5), pp. 1814. Date of Electronic Publication: 2016 Jun 01.
Typ publikacji :
Letter; Comment
Opinia redakcyjna
Tytuł :
Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study.
Autorzy :
Su TH; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Tseng TC; Division of Gastroenterology, Department of Internal Medicine, Taipei Tzuchi Hospital, The Buddhist Tzuchi Medical Foundation, Taipei, Taiwan.
Chou SW; National Taiwan University Health Data Research Center, Taipei, Taiwan.
Liu CH; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Wu SJ; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Chen DS; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Chen CL; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Kao JH; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
Hepatology (Baltimore, Md.) [Hepatology] 2016 Mar; Vol. 63 (3), pp. 721-30. Date of Electronic Publication: 2016 Jan 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis C/*epidemiology
Lymphoma/*epidemiology
Adult ; Aged ; Cohort Studies ; Female ; Hepatitis C/complications ; Hepatitis C/drug therapy ; Humans ; Interferons/therapeutic use ; Lymphoma/virology ; Male ; Middle Aged ; Proportional Hazards Models ; Taiwan/epidemiology
Czasopismo naukowe
Tytuł :
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion.
Autorzy :
Yang HC; Department of Microbiology, Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, and Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Chen CL
Shen YC
Peng CY
Liu CJ
Tseng TC
Su TH
Chuang WL
Yu ML
Dai CY
Liu CH
Chen PJ
Chen DS
Kao JH
Pokaż więcej
Źródło :
Hepatology (Baltimore, Md.) [Hepatology] 2013 Mar; Vol. 57 (3), pp. 934-43. Date of Electronic Publication: 2013 Feb 07.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms :
Hepatitis B, Chronic*/drug therapy
Hepatitis B, Chronic*/immunology
Hepatitis B, Chronic*/virology
Drug Monitoring/*methods
Hepatitis B Antibodies/*blood
Hepatitis B e Antigens/*genetics
Hepatitis B virus/*genetics
Sequence Analysis, DNA/*methods
Adult ; Antiviral Agents/therapeutic use ; Drug Resistance, Viral/genetics ; Female ; Hepatitis B e Antigens/immunology ; Hepatitis B virus/immunology ; Humans ; Interferons/therapeutic use ; Male ; Middle Aged ; Multivariate Analysis ; Polymerase Chain Reaction/methods ; Polymerase Chain Reaction/standards ; Predictive Value of Tests ; Promoter Regions, Genetic/genetics ; Ribavirin/therapeutic use ; Sequence Analysis, DNA/standards ; Viral Load/drug effects ; Viral Load/genetics ; Young Adult
Czasopismo naukowe
Tytuł :
Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.
Autorzy :
Tseng TC; Division of Gastroenterology, Department of Internal Medicine, Buddhist Tzu Chi General Hospital Taipei Branch, Taipei, Taiwan.
Liu CJ
Yang HC
Su TH
Wang CC
Chen CL
Hsu CA
Kuo SF
Liu CH
Chen PJ
Chen DS
Kao JH
Pokaż więcej
Źródło :
Hepatology (Baltimore, Md.) [Hepatology] 2013 Feb; Vol. 57 (2), pp. 441-50. Date of Electronic Publication: 2012 Dec 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
DNA, Viral/*blood
Hepatitis B Surface Antigens/*blood
Hepatitis B virus/*genetics
Hepatitis B, Chronic/*physiopathology
Adult ; Alanine Transaminase/blood ; Disease Progression ; Female ; Hepatitis B, Chronic/immunology ; Hepatitis B, Chronic/virology ; Humans ; Liver Cirrhosis/etiology ; Liver Cirrhosis/virology ; Male ; Middle Aged ; Taiwan/epidemiology ; Viral Load
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies